About your Search

20120912
20120912
Search Results 0 to 4 of about 5 (some duplicates have been removed)
made possible by the national captioning institute, inc., in cooperation with the united states house of representatives. any use of the closed-captioned coverage of the house proceedings for political or commercial purposes is expressly prohibited by the u.s. house of representatives.] the speaker pro tempore: the yeas are -- the speaker pro tempore: on this vote, the yeas are 354 and the nays are 62. the speaker pro tempore: on this vote, the yeas are 355 and the nays are 62, 2/3 being in the affirmative, the rules are suspended, the bill is passed and without objection, the motion to reconsider is laid on the table. the unfinished business is the vote on the motion of the the gentlewoman from california, to suspend the rules and pass h.r. 5865 on which the the yeas and nays are ordered as amended. the clerk will report the title of the bill. the clerk: h.r. 5865, a bill to promote the growth and competitiveness of american manufacturing. the speaker pro tempore: the question is, will the house suspend the rules and pass the bill as amended. members will record their votes by electr
in washington. consulates around the united states. we make sure they are adequately protected. particularly, when you get a rocket attack like that, it is an act of war and all to be treated as an act of war. i don't have the details yet. if we had an embassy personnel murdered, that is a sad situation. you have to express regret for the families that are involved. but the most important thing is we have to show the world that we are a nation that lives by international law. we expect other countries to live by international law. this is a violation of international law. your doctor take appropriate action. host: hear the statement from secretary clinton on the death of the personnel, ambassador christopher stevens and three others. the statement goes on from there. secretary clinton says all the americans we lost in yesterday's attacks made the ultimate sacrifice. we condemn this vicious and violent attack which took their lives, which they had committed to helping the libyan people reach for a better future." guest: of all your years ago the president made a gracious effort going around t
,000 people in the united states will wake up and sense something's wrong. they're more likely to be men than women, more likely to be people my age. but sometimes that unwelcome wakeup call arrives when you're young, when your career is just taking off. >> since you're obviously not a patient and i'm not getting anywhere, can you tell me where i can find a guy named lou who drives an ambulance, and i'll get out of your life. >> i'm lou. >> i was doing a film in florida and was partying pretty good, and was used to waking up not in great shape. but i woke up one morning, and my pinky was twitching, and it was just persistent. and i just... i realized that there was just nothing i could do to stop it. and i thought, is this like dts? who gets dts in a pinky? you know, with a lot of injury or a lot of catastrophic illness, it's like stepping off a curb and getting hit by a bus. but with parkinson's, it's like actually being stuck in the middle of the road while a bus is coming, and you can hear it, you have no idea how big it is, you have no idea how fast it's going, you have no idea whether it
's the leading cause of liver disease and liver transplants here in the united states. even with a transplant, the hepatitis will go right on attacking the new liver. this is a huge disease. it inflicts 170 million people around the world. which is just terrible, tragic. from a business perspective, these companies are involved. hep c can be a $20 million market opportunity. it's too darn good for many drug companies to pass up. now, i've talked about the game-changing new drugs developed for hep c on the shelf. but in recent months, there's been a reshuffling, major changes in the competitive race. i've got to keep you up on it. that's why tonight, i want to keep this opportunity in front of you and let you know who will benefit the most from the reshuffling of the order, the changes that have gone on and who can be the winners here. there are a lot of horses in this race. there was bristol-myers, abbott labs, johnson & johnson, six months ago bristol-myers was in the definite lead. but one of the patients taking their hep c drug in the clinical trial had a heart attack. and the company put
Search Results 0 to 4 of about 5 (some duplicates have been removed)

Terms of Use (10 Mar 2001)